GLOBAL BIRD FLU MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Bird flu, or avian influenza, refers to the diseases caused by influenza viruses that normally infect wild waterfowl and shorebirds. On rare occasions, these viruses can infect poultry and other bird and animal species, as well as humans. Over the past two decades, several subtypes of avian influenza viruses have emerged which can cause severe disease in poultry and some lead to serious illness or death in humans. The global spread of highly pathogenic avian influenza A (H5N1) virus from 1997 to 2006 raised considerable concern for its pandemic potential. While no sustained human-to-human transmission has been documented, sporadic human cases continue to occur, predominantly linked to contact with infected live or dead poultry.

Market Dynamics:

Global bird flu market growth is driven by factors such as the cyclic outbreaks of avian influenza in poultry farms which lead to huge economic losses, increasing risk of virus mutation and potential human pandemic, and rising government focus on prevention, control and surveillance of avian influenza viruses. However, factors such as lack of awareness regarding avian influenza in many developing countries, difficulties associated with vaccination programs in commercial poultry, and high costs related to developing effective anti-viral drugs and vaccines are restraining the market growth. The development of novel point-of-care diagnostic technologies and emerging economies improving prevention and control measures present high-impact opportunities for market expansion.

For instance, in March 2023, Virax Biolabs Group Limited, an innovative diagnostics company that focuses on the prevention, detection, and diagnosis of viral diseases, announced the distribution of an Avian Influenza A Virus real-time PCR test kit to CE-marked markets, namely the European Union. The test kit detects and distinguishes ribonucleic acid from AIV and the H5, H7, and H9 subtypes, including the H5N1 strain presently circulating in Europe.

Key Features of the Study:

• This report provides an in-depth analysis of the global bird flu market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bird flu market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Boehringer Ingelheim, Ceva Santé Animale, Zoetis, Merck & Co., Ringpu Biology, Yebio Bioengineering, FATRO, CAVAC, ChengDu Tecbond, QYH Biotech, Elanco, Phibro Animal Health, Vetoquinol, Hipra, Venkys, Anicon Labor GmbH, Medion Farma Jaya, Bioveta, Lohmann Animal Health, and Biogenesis Bago
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bird flu market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bird flu market

Global Bird Flu Market Detailed Segmentation:

• By Virus Type:
  • H5N1
  • H7N9
  • H5N6
  • H5N8
  • H10N8
  • H9N2
  • Others 
• By Test Type:
  • PCR Tests
  • ELISA Tests
  • Hemagglutination Assays
  • Virus Isolation Tests
  • Next Generation Sequencing
  • Others
• By Treatment Type:
  • Vaccines
  • Antiviral Medication
  • Immunomodulators
  • Others
• By Animal Type:
  • Chickens
  • Ducks
  • Geese & Swans
  • Pigeons
  • Guinea Fowls
  • Turkeys
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles:
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Zoetis
  • Merck & Co.
  • Ringpu Biology
  • Yebio Bioengineering
  • FATRO
  • CAVAC
  • ChengDu Tecbond
  • QYH Biotech
  • Elanco
  • Phibro Animal Health
  • Vetoquinol
  • Hipra
  • Venkys
  • Anicon Labor GmbH
  • Medion Farma Jaya
  • Bioveta
  • Lohmann Animal Health
  • Biogenesis Bago